Screener Companies About
OTC:PCYN
Healthcare Drug Manufacturers - Specialty & Generic

PROCYON CORP

A specialized entity reporting $5.0M revenue with a negative net income of -$341k driven by substantial operating expenses and interest costs.

■ Key Metrics

Revenue
$5.0M
Net Income
$-341.1K
Gross Profit
$3.9M
Operating Cash Flow
$-61.3K
Total Assets
$3.2M
Shareholders' Equity
$2.3M

⚖ Investment Thesis

Bull Case

Investors may view the substantial current assets of $2.4M and positive interest income as potential stabilizers while monitoring for a turnaround in operational efficiency to close the widening loss gap.

Bear Case

The stock is heavily exposed to solvency risks given the -$341k net loss, -$2.3M deficit in retained earnings, and negative cash flow from operations which limits reinvestment capabilities without external financing.

◉ About PROCYON CORP

PROCYON CORP (PCYN) is a mid-cap OTC company with approximately $5.0M in revenue and $3.9M in gross profit, currently navigating significant operational losses of -$0.3M in the most recent year.

⚙ Analysis

Management Discussion

The company generated $5.0M in revenue but faced a sharp decline in profitability with net income dropping from -$0.1M to -$0.3M, primarily due to non-cash adjustments and high operating costs exceeding gross margins.

Industry Overview

The company operates within a sector where maintaining positive cash flow from operations is critical, yet this firm currently faces challenges with operating expenses of $4.1M significantly eroding its $3.9M gross profit.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric20232024
Revenue$4.7M$5.0M
Cost of Revenue$1.1M$1.1M
Gross Profit$3.6M$3.9M
Operating Expenses$3.7M$4.1M
Operating Income$-97.4K$-231.7K
R&D$30.6K$30.1K
G&A$1.8M$2.0M
Stock-Based Comp$0$7.7K
Depreciation$52.8K$81.7K
Other OpEx$1.8M$2.1M
Non-Operating Income$32.0K$60.4K
Interest Income$11.8K$24.6K
Pre-Tax Income$-65.4K$-171.3K
Income Tax$-15.1K$169.9K
Continuing Ops$-50.2K$-341.1K
Discontinued Ops$0$0
Net Income$-50.2K$-341.1K
Minority Interest$0$0
Net to Common$-50.2K$-341.1K
Metric20232024
Current Assets$2.2M$2.4M
Accounts Receivable$494.0K$512.9K
Inventory$431.4K$510.0K
Prepaid Expenses$298.5K$434.1K
Other Current Assets$1.0M$908.8K
Long-Term Assets$1.3M$838.5K
PP&E (Net)$281.0K$262.0K
Operating Leases$527.2K$338.1K
Other LT Assets$517.9K$238.4K
Total Assets$3.6M$3.2M
Current Liabilities$626.1K$769.2K
Accounts Payable$175.1K$160.9K
Current Leases$173.6K$180.7K
Other Current Liab$277.5K$427.6K
Long-Term Liabilities$319.9K$147.9K
LT Operating Leases$319.9K$139.2K
Other LT Liab$0$8.7K
Total Liabilities$946.0K$917.1K
Shareholders' Equity$2.6M$2.3M
Paid-In Capital$35.6K$41.1K
Retained Earnings$-2.0M$-2.3M
Total L&E$3.6M$3.2M
Metric20232024
Net Income (CFO)$-50.2K$-341.1K
Non-Cash Adjustments$220.2K$14.9K
Working Capital Changes$-24.5K$265.0K
Cash from Operations$145.5K$-61.3K
Capital Expenditures$180.1K$63.9K
Cash from Investing$-454.6K$-63.9K
Cash from Financing$0$0
FX Effect$0$0
Net Change in Cash$-309.1K$-125.2K
Beginning Cash$760.4K$451.3K
Ending Cash$451.3K$326.1K

Frequently Asked Questions

How does PROCYON CORP make money?

Primary revenue streams include core operations generating $3.9M gross profit against $4.1M total operating expenses, alongside non-operating gains totaling $60k from discontinued or other activities.

What are the main risks for PCYN?

Persistent net losses of -$341k, high operating expense ratio relative to gross profit, significant accumulated retained earnings deficit of -$2.3M, and negative cash flow from operations of -$61k.

What is PCYN's competitive advantage?

Strong liquidity position with over $2.4M in current assets and a diversified asset base including $838k in long-term assets providing operational flexibility.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.